Biosplice Therapeutics. 964 likes · 12 talking about this. Biosplice is developing first-in-class, small-molecule therapeutics based on pioneering... ... <看更多>
Biosplice Therapeutics has produced fresh biological insights and unique chemical equity that delivers therapeutic modulation of alternative splicing by ...
Biosplice Therapeutics, Inc. (formerly Samumed, LLC) is a private biopharmaceutical company based in San Diego, California. It was founded in 2008 by Osman ...
Biosplice Therapeutics is in the medical research and development for tissue-level regeneration. With their platform's origins in small molecule-based Wnt ...
Biosplice is developing first-in-class, small-molecule therapeutics based on pioneering science of alternative pre-mRNA splicing. biosplice.com Joined March ...
Biosplice is a biopharmaceutical company developing first-in-class therapies that harness RNA alternative splicing. The Company's scientific platform is ...
Biosplice Therapeutics, Inc., a clinical-stage biotechnology company pioneering first-in-class therapeutics based on small-molecule inhibition of CLK/DYRK ...
Biosplice Therapeutics is a clinical-stage biotechnology company pioneering therapeutics based on alternative pre-mRNA splicing for major diseases.
#13.
Biosplice Therapeutics Company Profile: Funding & Investors
Biosplice Therapeutics General Information ... Operator of a tissue-level therapeutic drugs company focused on osteoarthritis and oncology, with early-stage ...
#14.
Cirtuvivint by Biosplice Therapeutics for Metastatic ...
Biosplice Therapeutics is a biotechnology company that develops CLK/DYRK kinase based small-molecule drugs for musculoskeletal diseases, ...
#15.
Biosplice Therapeutics Inc - Company Profile and News
Biosplice Therapeutics, Inc. operates as a biotech company. The Company focuses on osteoarthritis and oncology, with early-stage programs in neurology and ...
#16.
Biosplice Therapeutics - Company Profile
What does Biosplice Therapeutics do? Provider of splicing modulation development solutions for multiple diseases. It is a clinical-stage biotechnology company ...
#17.
Biosplice Therapeutics (formerly Samumed)
Biosplice Therapeutics (formerly Samumed) ... Medical research and development for tissue-level regeneration. Launch date. 2008. Employees.
#18.
Biosplice Therapeutics, Inc. | Institution outputs
Outputs for Biosplice Therapeutics, Inc. Research outputs. 1 April 2022 - 31 March 2023. The research outputs (Count and Share) on this page only include ...
#19.
BioSplice Therapeutics (formerly Samumed)
Project Location San Diego, CA ; Owner BioSplice Therapeutics (formerly Samumed) ; Architect Ware Malcomb ; Market Life Science, Special Projects ; Services General ...
#20.
Biosplice therapeutics - Email Address & Phone Number
Biosplice is developing first-in-class, small-molecule therapeutics based on pioneering science of alternative pre-mRNA splicing.
#21.
Biosplice's high valuation turned heads. Layoffs now raise ...
SAN DIEGO — Biosplice, once the world's most valuable biotech startup, is laying off nearly a quarter of its workforce and has stopped ...
#22.
Biosplice Therapeutics
The latest news, comment and analysis about Biosplice Therapeutics from the Vantage editorial team.
#23.
Biosplice Therapeutics Closes $120 Million in Equity
Biosplice Therapeutics Closes $120 Million in Equity Financing to Advance Its Alternative Splicing Platform. April 15, 2021 10:55 ET | Source: Biosplice ...
Biosplice is developing first-in-class, small-molecule therapeutics based on pioneering science of alternative pre-mRNA splicing.
#25.
Biosplice Therapeutics
Biosplice Therapeutics, Inc. is a private biopharmaceutical company based in San Diego, California. It was founded in 2008 by Osman Kibar.
#26.
NCT03742518
沒有這個頁面的資訊。
#27.
Biosplice Therapeutics Inc.
Biosplice Therapeutics Inc. has described 1H-pyrrolo[2,3-b]pyridines acting as dual-specificity tyrosine-(Y)-phosphorylation regulated kinase 1A ...
#28.
Biosplice Therapeutics: Contact Details and Business Profile
Biosplice is developing first-in-class, small-molecule therapeutics based on pioneering science of alternative pre-mRNA splicing.
#29.
Organization | Biosplice Therapeutics
Founded: San Diego CA United States (2008). Biosplice Therapeutics. Organization Overview. First Clinical Trial. 2014. NCT02095548. First Marketed Drug.
Based in San Diego, CA, Biosplice is developing small-molecule therapeutics based on pioneering science of alternative pre-mRNA splicing.
#35.
Biosplice Therapeutics
Biosplice Therapeutics. company in San Diego, United States. Samumed; Wintherix. In more languages. Spanish. No label defined.
#36.
All individual trials at Biosplice Therapeutics, Inc.
Status Sponsor Trial ID Completion date Days overdue
reported‑late Biosplice Therapeutics, Inc. NCT02536833 2017‑04‑20 94
reported Biosplice Therapeutics, Inc. NCT03122860 2018‑04‑30
ongoing Biosplice Therapeutics, Inc. NCT03706521 2020‑07‑22
#37.
Biosplice Therapeutics
About Biosplice Therapeutics. Upcoming Summits. 2023 Atlanta CIO Executive Leadership Summit. 18 August, 2023, 8 AM-3 30 PM EST Register ...
#38.
Buy or sell Biosplice Therapeutics stock pre IPO ...
About Biosplice Therapeutics Stock ... Samumed is in the medical research and development for tissue-level regeneration. With their platform's origins in small ...
#39.
Buy Biosplice Therapeutics stock and other Pre-IPO shares ...
Biosplice Therapeutics valuation, funding rounds, company filings, leadership, and news. Buy Biosplice Therapeutics stock or other Pre-IPO shares on ...
#40.
Biosplice Therapeutics Inc.
Biosplice's mission is to restore health by delivering first-in-class therapies that harness alternative splicing. Our scientific platform is based on ...
#41.
Biosplice Therapeutics, Inc. - Scrip - Informa
Biosplice Therapeutics, Inc. https://www.biosplice.com. Already a Biomedtracker subscriber? You have access to the full company record through your ...
#42.
Biosplice Therapeutics Inc
Biosplice Therapeutics Inc. No information available. Studies; About Us. All Studies; Sponsoring; Collaborating; Conducting. Status. Recruiting.
The leading Osteoarthritis Companies such as Biosplice Therapeutics, Gilead Sciences, Flexion Therapeutics, GlaxoSmithKline, Levicept, Arthrogen ...
#44.
Biosplice Therapeutics legal jobs
Biosplice Therapeutics is in the medical research and development for tissue-level regeneration. Website. www.biosplice.com/default.aspx. HQ location.
#45.
Patents Assigned to BioSplice Therapeutics, Inc.
Assignee: BioSplice Therapeutics, Inc. Inventors: Sunil Kumar KC, Gopi Kumar Mittapalli, Brian Joseph Hofilena, Joseph Timothy Marakovits, ...
#46.
POS1351 A PHASE 2, 104-WEEK STUDY OF REPEAT ...
Acknowledgements: NIL. Disclosure of Interests Yusuf Yazici Shareholder of: Biosplice Therapeutics, Employee of: Biosplice Therapeutics, Christopher Swearingen ...
#47.
Biosplice Therapeutics
Biosplice Therapeutics is in the medical research and development for tissue-level regeneration. Stage: A. Total Funds Raised: $120.0M.
#48.
Biosplice Therapeutics, Inc. Asset Profile
Founded in 2020 and based in California, US, Biosplice Therapeutics, Inc. (Biosplice), formerly Samumed, LLC operates as a biotechnology company that ...
#49.
Biosplice Therapeutics, Inc, 9360 Towne Centre Dr, San ...
Get directions, reviews and information for Biosplice Therapeutics, Inc in San Diego, CA. You can also find other Biotechnology Products & Services on ...
#50.
Company:Biosplice Therapeutics
Biosplice Therapeutics, Inc. (formerly Samumed, LLC) is a private biopharmaceutical company based in San Diego, California. It was founded in 2008 by Osman ...
#51.
Epic Sciences and Biosplice Therapeutics Announce ...
Biosplice Therapeutics, Inc., a clinical-stage biotechnology company pioneering therapeutics based on CLK/DYRK kinase modulation for major ...
#52.
Biosplice Therapeutics Closes $120 Million in Equity ...
New investors include Eventide, aMoon, SymBiosis II, Sands Capital and VeritionProceeds to support Biosplice's clinical development of ...
#53.
Heavily Funded Biosplice Dumps Its Hair Loss Treatment
Heavily funded but small-in-size biotech Biosplice has scrapped dalosirvat, its treatment for hair loss in men, which was in late-stage ...
#54.
Osteoarthritis today: Lost in translation?
The current therapeutic options are inadequate, providing only a moderate symptom relief ... 1 Biosplice Therapeutics Inc., San Diego, CA, United States.
#55.
EPIC SCIENCES AND BIOSPLICE THERAPEUTICS ...
Biosplice's mission in Oncology is to deliver first-in-class therapies that target alternative splicing. Our foundational discoveries in Wnt ...
#56.
First Subject Dosed in Biosplice Therapeutics Phase 1b ...
Biosplice Therapeutics, Inc. recently announced the dosing of the first subject in a Phase 1b, open-label, multi-center, dose-escalation, dose expansion.
#57.
Biosplice announces data from osteoarthritis clinical trial
Biosplice Therapeutics, a clinical-stage biotech company pioneering first-in-class small molecule therapeutics, has announced potential structure-modifying ...
#58.
Biosplice Announces Interim Data from Phase 3 Long ...
SAN DIEGO, Dec. 15, 2022 (GLOBE NEWSWIRE) -- Biosplice Therapeutics, Inc. (“Biosplice”), a clinical-stage biotechnology company pioneering ...
#59.
Biosplice Therapeutics Closes $120 Million in Equity ...
(“Biosplice”), a clinical-stage biotechnology company pioneering therapeutics based on alternative pre-mRNA splicing for major diseases, ...
#60.
Biosplice secures $120M to advance splicing platform
Biosplice Therapeutics has closed $120 million in equity financing to support clinical development of lorecivivint for treating ...
#61.
Turkish Billionaire's Biotech Firm Accused of 'Scam' by ...
The parent company of Biosplice Therapeutics Inc., founded by the billionaire Osman Kibar, is facing litigation over claims it allowed a ...
#62.
Biosplice Therapeutics Announced New Clinical Data for ...
Biosplice Therapeutics Announced New Clinical Data for Cirtuvivint (SM08502) at the European Society for Clinical Oncology Meeting.
#63.
Biosplice therapeutics hi-res stock photography and images
RF 2JKCRY8–Person holding smartphone with logo of US company Biosplice Therapeutics Inc. on screen in front of website. Focus on phone display.
#64.
Chad Henry Atlas # 320686
Address: Biosplice Therapeutics, Inc., 9360 Towne Centre Drive, San Diego, CA 92121. Phone: 858-365-0233 | Fax: 858-552-9315.
#65.
0 Jobs at Biosplice Therapeutics, Inc. in San Diego, CA
Find 0 available Biosplice Therapeutics, Inc. jobs in San Diego, CA at Ladders. Join Ladders to find the latest open jobs and get noticed by over 90000 ...
#66.
Biosplice Therapeutics Closes $120 Million in Equity ...
Biosplice Therapeutics Closes $120 Million in Equity Financing to Advance Its Alternative Splicing Platform. NASDAQ Market News April 15, 2021.
#67.
BioSplice
Stemming from foundational discoveries in Wnt pathway modulation, Biosplice has elucidated novel biology linking CLK/DYRK kinases to the therapeutic regulation ...
#68.
Biosplice Therapeutics Inc Help Desk Technician Salaries
What is the average salary for a Help Desk Technician at Biosplice Therapeutics Inc in the United States? Based on our data, it appears that the optimal ...
#69.
Andrew John Armstrong | Scholars@Duke profile: Research
... or Chemotherapy in Subjects with Advanced Solid Tumors. Clinical TrialPrincipal Investigator · Awarded by Biosplice Therapeutics, Inc · 2022 - 2027 ...
#70.
Epic Sciences And Biosplice Therapeutics Announce ...
Biosplice Therapeutics, Inc., a clinical-stage biotechnology company pioneering therapeutics based on CLK/DYRK kinase modulation for major ...
#71.
Biosplice Therapeutics - Company Info, Employees & ...
View Biosplice therapeutics biosplice.com location in 9381 judicial dr, san diego, california, 92121, revenue, industry and description.
#72.
Abstract 5019: Next-generation DYRK1A inhibitors as a new ...
Abstract 5019: Next-generation DYRK1A inhibitors as a new therapeutic approach for the treatment of hematological malignancies ... 1Biosplice ...
Competitor Name Revenue Number of Employees Employee Growth Total Funding
#1. DiaCarta $4.8M 51 2% $53M
#2. Mission Bio $29.6M 125 ‑12% $110M
#3. Quadrants Scien... $0.4M 6 0% N/A
#74.
Biosplice Therapeutics Patents - Key Insights and Stats
Biosplice Therapeutics has 471 patents globally, out of which 220 have been granted. Of these 471 patents, more than 80% patents are active.
#75.
Solicitation for submission of Pre-LOIs for Cirtuvivint
... kinases (DYRKs) that is under development by CTEP as an anticancer agent in collaboration with Biosplice Therapeutics.
#76.
Search Orphan Drug Designations and Approvals - FDA
Biosplice Therapeutics, Inc. 9360 Towne Centre Drive San Diego , California 92121. United States The sponsor address listed is the last reported by the sponsor ...
#77.
Epic Sciences, Biosplice Therapeutics Partner on ...
Biosplice will use Epic's liquid biopsy platform in several clinical trials, including for its Cirtuvivint investigative drug for solid ...
#78.
8-K
Marchand served as Chief Operating Officer of Biosplice Therapeutics, Inc. (“Biosplice”), a privately held biopharmaceutical company, since ...
#79.
Troy Cox, Susannah Gray and Karen McGinnis Join ...
SAN DIEGO, April 20, 2021 (GLOBE NEWSWIRE) — Biosplice Therapeutics, a clinical-stage biotechnology company pioneering therapeutics based on ...
#80.
Biosplice Therapeutics Jobs
Biosplice Therapeutics Open Jobs. Are you ready to level up your career? Check out these open roles at Biosplice Therapeutics. View All Jobs ...
#81.
A Phase 3, 28-Week, Multicenter, Randomized, Double- ...
... 3Biosplice Therapeutics, Inc., San Diego, CA, 4Biosplice Therapeutics, Santa Clarita, CA, 5 Alpine Immunesciences, San Diego, CA, 6Biosplice Therapeutics ...
#82.
EPIC SCIENCES AND BIOSPLICE ... - Knop News
27, 2022 /PRNewswire/ -- Biosplice Therapeutics, Inc., a clinical-stage biotechnology company pioneering therapeutics based on CLK/DYRK kinase ...
#83.
Biosplice Reviews: What Is It Like to Work ...
6 Biosplice reviews. A free inside look at company reviews and salaries posted anonymously by employees.
#84.
The Pan-Clk/Dyrk Inhibitor Cirtuvivint (SM08502) Exposes ...
Bossard: Biosplice Therapeutics: Current Employment. McMillan: Prizer: Ended employment in the past 24 months.
#85.
Alternative splicing (AS) regulation as a novel therapeutic ...
... were used to analyse the effect of SM09419 (provided by Biosplice) or PRI-724 (Wnt/β-catenin inhibitor) on cell viability (MTS assays).
#86.
Osman Kibar lays down his hand at Samumed, stepping ...
... be found on Thursday, when the company added another $120 million to its coffers and quietly changed its name to Biosplice Therapeutics.
#87.
Haisco to Pay USD150 Million for China Rights to New US ...
Biosplice Therapeutics is a clinical-stage biotech company that develops therapeutics based on alternative pre-mRNA splicing for major ...
#89.
Biotech Veterans Troy Cox, Susannah Gray and Karen ...
Biosplice Therapeutics, Inc., a clinical-stage biotechnology company pioneering therapeutics based on alternative pre-mRNA splicing for ...
#90.
Biosplice Therapeutics Inc. - Summary from LegiStorm
LegiStorm's information on Biosplice Therapeutics Inc. including any related organizations, trips sponsored, lobbying information, earmarks and more.
#91.
EDGAR Filing Documents for 0001848940-21-000001
BioSplice Therapeutics, Inc. (Filer) CIK : 0001848940 (see all company filings). IRS No. : 000000000 | State of Incorp.
#92.
Biosplice therapeutics
Biosplice therapeutics https://finance.yahoo.com/news/biosplice-therapeutics-announced-clinical-data-130000998.html WebBiosplice Therapeutics is in the ...
#93.
Knee Osteoarthritis Market to Witness Upsurge in Growth ...
... Inc., Biosplice Therapeutics, Angitia Biopharmaceuticals, ... Emerging Degenerative Disc Disease therapies in the different phases of ...
#97.
Balding cure reddit
Biosplice Therapeutics Logo. Invalid Date, A NEW £2,000 stem cell procedure which may actually reverse hair loss is being called the world's first "cure for ...
biosplice therapeutics 在 Biosplice Therapeutics 的推薦與評價
Biosplice Therapeutics. 964 likes · 12 talking about this. Biosplice is developing first-in-class, small-molecule therapeutics based on pioneering... ... <看更多>